Further research also should consider whether differentially recruiting
good patients
can impact the ethnic/racial diversity or other characteristics of trial participants in ways that may bias the outcomes or conclusions of therapeutic trials.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
Sunday, January 25, 2009
Diversity of participants in clinical trials in an academic medical center
Wiley InterScience :: JOURNALS :: Cancer
Further research also should consider whether differentially recruitinggood patients can impact the ethnic/racial diversity or other characteristics of trial participants in ways that may bias the outcomes or conclusions of therapeutic trials.
Further research also should consider whether differentially recruiting
good patients can impact the ethnic/racial diversity or other characteristics of trial participants in ways that may bias the outcomes or conclusions of therapeutic trials.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.